188 related articles for article (PubMed ID: 7127906)
1. Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.
Mitchell DM; Fitzharris P; Knight RA; Schild GC; Snaith ML
Clin Exp Immunol; 1982 Aug; 49(2):290-6. PubMed ID: 7127906
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of specific in vitro antibody production following influenza immunization.
Mitchell DM; Fitzharris P; Knight RA; Schild GC
Clin Exp Immunol; 1982 May; 48(2):491-8. PubMed ID: 7105493
[TBL] [Abstract][Full Text] [Related]
3. Defective B cell function in systemic lupus erythematosus.
Pelton BK; Denman AM
Clin Exp Immunol; 1982 Jun; 48(3):513-8. PubMed ID: 6981471
[TBL] [Abstract][Full Text] [Related]
4. Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.
Sigfusson A; Babbage JW; Souhami RL
Clin Exp Immunol; 1985 May; 60(2):396-402. PubMed ID: 4006304
[TBL] [Abstract][Full Text] [Related]
5. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.
Yarchoan R; Murphy BR; Strober W; Clements ML; Nelson DL
J Immunol; 1981 Nov; 127(5):1958-63. PubMed ID: 7299119
[TBL] [Abstract][Full Text] [Related]
6. Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.
Hari Kumar MK; Knight RA; Snaith ML
Clin Exp Immunol; 1984 Oct; 58(1):21-8. PubMed ID: 6236917
[TBL] [Abstract][Full Text] [Related]
7. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
9. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
10. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
[TBL] [Abstract][Full Text] [Related]
11. A study of the functional capabilities of human neonatal lymphocytes for in vitro specific antibody production.
Yarchoan R; Nelson DL
J Immunol; 1983 Sep; 131(3):1222-8. PubMed ID: 6309961
[TBL] [Abstract][Full Text] [Related]
12. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination of patients with systemic lupus erythematosus.
Mercado U; Acosta H; Avendaño L
Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydrocortisone on PWM and LPS-induced immunoglobulin production in blood leucocytes from patients with systemic lupus erythematosus.
Halliday GM; Salaman MR
J Clin Lab Immunol; 1983 Nov; 12(3):141-5. PubMed ID: 6663607
[TBL] [Abstract][Full Text] [Related]
15. The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.
Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
Clin Exp Immunol; 1984 Sep; 57(3):535-40. PubMed ID: 6235994
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of polyclonal B-cell activity in systemic lupus erythematosus.
Levinson AI; Dziarski A; Pincus T; deHoratius RJ; Zweiman B
J Clin Lab Immunol; 1981 Jan; 5(1):17-22. PubMed ID: 6971331
[TBL] [Abstract][Full Text] [Related]
18. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
[TBL] [Abstract][Full Text] [Related]
19. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
Waldman RH; Ganguly R
Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
